Counterpoint Mutual Funds LLC Takes Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Counterpoint Mutual Funds LLC acquired a new stake in Acadia Healthcare, purchasing 32,428 shares valued at approximately $736,000 during the second quarter.
• Analyst recommendations on ACHC have varied, with Guggenheim lowering their target price from $36.00 to $29.00 while Cowen maintained a "buy" rating, indicating mixed sentiments in the market.
• Acadia Healthcare recently reported a quarterly earnings per share (EPS) of $0.83, exceeding estimates and indicating a year-over-year revenue increase of 9.2%, with a FY 2025 EPS guidance of 2.450-2.65.

Counterpoint Mutual Funds LLC acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 32,428 shares of the company's stock, valued at approximately $736,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after purchasing an additional 1,234 shares during the last quarter. UMB Bank n.a. lifted its stake in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares during the last quarter. State of Wyoming acquired a new stake in Acadia Healthcare during the fourth quarter valued at approximately $56,000. Covestor Ltd lifted its stake in Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after purchasing an additional 812 shares during the last quarter. Finally, Parallel Advisors LLC lifted its stake in Acadia Healthcare by 1,120.3% during the second quarter. Parallel Advisors LLC now owns 5,174 shares of the company's stock valued at $117,000 after purchasing an additional 4,750 shares during the last quarter.

Analyst Upgrades and Downgrades

ACHC has been the subject of several recent research reports. Guggenheim cut their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Barclays cut their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Mizuho cut their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research note on Wednesday, August 13th. Cowen restated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and an average target price of $39.00.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $23.02 on Tuesday. The company's fifty day moving average is $21.83 and its 200-day moving average is $23.72. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $77.49. The firm has a market cap of $2.13 billion, a price-to-earnings ratio of 15.25, a price-to-earnings-growth ratio of 4.36 and a beta of 0.89. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same quarter in the prior year, the business posted $0.91 EPS. Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.